Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | Mr. Shawn NeumanSenior VP, General Counsel & Secretary | -21,11k | 58,27k | Sale to Issuer | 2,76 | 117,75k | -15,21% |
| 2026-04-15 | Mr. Thomas E. WirthExec. VP & CFO | -35,68k | 98,48k | Sale to Issuer | 2,76 | 936,85k | -3,67% |
| 2026-04-15 | Mr. Daniel PalazzoSenior VP, CAO & Treasurer | -2,41k | 6,64k | Sale to Issuer | 2,76 | 246,75k | -0,97% |
| 2026-04-15 | Mr. William D. ReddExec. VP and Senior MD of Austin & Metro DC Regions | -10,01k | 27,62k | Sale to Issuer | 2,76 | 666,36k | -1,48% |
| 2026-04-15 | Mr. H. Jeffrey DeVuonoExec. VP & Senior MD of Life Sciences | -24,63k | 67,98k | Sale to Issuer | 2,76 | 771,00k | -3,10% |
| 2026-04-15 | Mr. Gerard H. SweeneyPresident, CEO & Trustee | -5,99k | 16,53k | Sale to Issuer | 2,76 | 4,17M | -0,14% |
| 2026-02-27 | Mr. H. Jeffrey DeVuonoExec. VP & Senior MD of Life Sciences | -3,66k | 11,58k | Sale to Issuer | 3,16 | 795,63k | -0,46% |
| 2026-02-27 | Mr. William D. ReddExec. VP and Senior MD of Austin & Metro DC Regions | -3,42k | 10,81k | Sale to Issuer | 3,16 | 676,37k | -0,50% |
| 2026-02-27 | Mr. Thomas E. WirthExec. VP & CFO | -4,94k | 15,61k | Sale to Issuer | 3,16 | 972,54k | -0,51% |
| 2026-02-27 | Mr. Gerard H. SweeneyPresident, CEO & Trustee | -14,28k | 45,12k | Sale to Issuer | 3,16 | 4,17M | -0,34% |
| 2026-02-04 | Mr. Gerard H. SweeneyPresident, CEO & Trustee | -4,18k | 11,82k | Sale to Issuer | 2,83 | 3,55M | -0,12% |
| 2026-02-04 | Mr. Daniel PalazzoSenior VP, CAO & Treasurer | -2,31k | 6,52k | Sale to Issuer | 2,83 | 192,19k | -1,19% |
| 2026-02-04 | Mr. Thomas E. WirthExec. VP & CFO | -2,70k | 7,64k | Sale to Issuer | 2,83 | 767,28k | -0,35% |
| 2026-01-23 | Mr. William D. ReddExec. VP and Senior MD of Austin & Metro DC Regions | -26,83k | 81,29k | Sale to Issuer | 3,03 | 534,22k | -4,78% |
| 2026-01-23 | Mr. H. Jeffrey DeVuonoExec. VP & Senior MD of Life Sciences | -40,54k | 122,82k | Sale to Issuer | 3,03 | 643,37k | -5,93% |
| 2026-01-23 | Mr. Daniel PalazzoSenior VP, CAO & Treasurer | -7,43k | 22,52k | Sale to Issuer | 3,03 | 194,50k | -3,68% |
| 2026-01-23 | Mr. Shawn NeumanSenior VP, General Counsel & Secretary | -22,60k | 68,48k | Sale to Issuer | 3,03 | 100,99k | -18,29% |
| 2026-01-23 | Mr. Thomas E. WirthExec. VP & CFO | -70,42k | 213,37k | Sale to Issuer | 3,03 | 769,98k | -8,38% |
| 2026-01-23 | Mr. Gerard H. SweeneyPresident, CEO & Trustee | -23,36k | 70,77k | Sale to Issuer | 3,03 | 3,55M | -0,65% |
| 2026-01-23 | Mr. George D. JohnstoneInitié | -50,91k | 154,26k | Sale to Issuer | 3,03 | 574,36k | -8,14% |
| 2025-11-10 | Mr. Gerard H. SweeneyPresident, CEO & Trustee | 88,50k | 298,88k | Achat | 3,38 | 3,04M | 3,00% |
| 2025-10-30 | Mr. James C. DiggsChair of the Board & Lead Independent Trustee | -23,19k | 80,47k | Vente | 3,47 | 128,67k | -15,27% |
| 2025-07-07 | Mr. Gerard H. SweeneyPresident, CEO & Trustee | -2,95k | 12,66k | Sale to Issuer | 4,29 | 2,95M | -0,10% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
